Zeria Pharmaceutical Co. Ltd. | Ownership
Companies that own Zeria Pharmaceutical Co. Ltd.
The Vanguard Group, Inc.
968,353
1.82%
11,700
0%
07/31/2018
Norges Bank Investment Management
784,499
1.48%
182,299
0%
12/31/2017
Nomura Asset Management Co., Ltd.
737,898
1.39%
20,599
0.01%
07/31/2018
Daiwa Asset Management Co. Ltd.
348,400
0.66%
8,200
0.01%
07/31/2018
Invesco Capital Management LLC
336,559
0.63%
0
0.01%
09/06/2018
Nikko Asset Management Co., Ltd.
317,799
0.6%
-7,901
0%
08/20/2018
Dimensional Fund Advisors LP
263,398
0.5%
-20,800
0%
04/30/2018
BlackRock Fund Advisors
254,300
0.48%
0
0%
09/06/2018
BNY Mellon Asset Management North America Corp.
167,300
0.32%
-1,400
0%
09/06/2018
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
129,200
0.24%
-2,400
0.01%
04/09/2018
| Address |
10-11 Nihonbashi Kobuna-cho
Tokyo Tokyo 103
Japan
|
|
Employees
|
- |
| Website |
http://www.zeria.co.jp |
| Updated |
07/08/2019 |
| Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. It also develops and distributes agricultural and industrial chemicals, and reagents. It operates through the following segments: Ethical Pharmaceuticals, Consumer Healthcare, and Others. |
